Tag Archives: ahead

Amarin’s Vascepa nabs ADA backing to cut heart risks, even ahead of FDA review

The cardiovascular outcomes results Amarin rolled out for its fish oil-derived Vascepa may not have impressed all, but at least one leading health organization in the U.S. is ready to throw its weight behind the drug, even before an FDA review of the label expansion. The American Diabetes Association (ADA) on Wednesday said its 2019… Read More »

AstraZeneca, Merck's Lynparza plows ahead in ovarian cancer with $1B-plus approval, phase 3 data

The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More »